WUNVI Trademark

Trademark Overview


On Tuesday, November 22, 2022, a trademark application was filed for WUNVI with the United States Patent and Trademark Office. The USPTO has given the WUNVI trademark a serial number of 97688083. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, August 1, 2024. This trademark is owned by Incyte Holdings Corporation. The WUNVI trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of graft versus host disorders

Providing healthcare information to physicians, patients and caregivers relating to diagnosis and treatment of medical diseases and disorders
wunvi

General Information


Serial Number97688083
Word MarkWUNVI
Filing DateTuesday, November 22, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, August 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 4, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of graft versus host disorders
Goods and ServicesProviding healthcare information to physicians, patients and caregivers relating to diagnosis and treatment of medical diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 14, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIncyte Holdings Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19803

Party NameIncyte Holdings Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19803

Trademark Events


Event DateEvent Description
Friday, November 25, 2022NEW APPLICATION ENTERED
Wednesday, December 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 31, 2023ASSIGNED TO EXAMINER
Thursday, June 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 14, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 4, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 12, 2024SOU EXTENSION 1 FILED
Monday, February 12, 2024SOU EXTENSION 1 GRANTED
Tuesday, February 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU EXTENSION 2 GRANTED
Thursday, August 1, 2024SOU EXTENSION 2 FILED